Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy

BACKGROUND: Recently, we reported an association of a novel cancer testis (CT) antigen, sperm-associated antigen 9 (SPAG9) expression in breast cancer clinical samples, indicating its potential role in carcinogenesis. Around 15% breast cancers are designated as triple-negative for which treatment mo...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Sinha, Abhilasha, Agarwal, Sumit, Parashar, Deepak, Verma, Archana, Saini, Shikha, Jagadish, Nirmala, Ansari, Abdul S, Lohiya, Nirmal K, Suri, Anil
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2013
Hasła przedmiotowe:
Research
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848771/
https://ncbi.nlm.nih.gov/pubmed/24330581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-69
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy